Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: phoenix_rising who wrote (2003)	7/25/2016 11:07:16 AM
From: eico20	Read Replies (1) of 2026

No bump yet, but agreed, Sandoz screwed Apri over, taking the largest partner deal and not selling after getting their first batches, they pulled an Abbott. According to the 10K/Q's - What happened was on a test batch to the EMA, there were some stability issues, the manufacturer fixed the issue and the EMA accepted the fix and all the partners agreed with it, except for Sandoz. Sandoz implemented a zero tolerance policy on quality due to their product recalls problem in the EU. So once they sold out their inventory they stopped selling Vitaros in Germany, Sweden and Belgium, and stopped moving on Asia. Ferring is hungry and now has UK, Lat Am and all of Sandoz. Apricus should get some cash for facilitating the change of partnership. Luckily Sandoz cooperated and didn't go to court. This is great news. Ferring will move on launching in many countries asap IMO, which should be a big addition to sales. Don't expect a PPS move until more sales start coming in.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next